Vora A, Goulden N, Mitchell C, et al : Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003) : a randomised controlled trial. Lancet Oncol 2014 ; 15 : 809-818.
Vora A, Goulden N, Wade R, et al : Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003) : a randomised controlled trial. Lancet Oncol 2013 ; 14 : 199-209.
Toyoda Y, Manabe A, Tsuchida M, et al : Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood. J Clin Oncol 2000 ; 18 : 1508-1516.